Arcellx Director Sells 6,000 Shares for $450,000 [Yahoo! Finance]
UBS Initiates Coverage of Arcellx With Bullish Outlook as Biotech Fundamentals Inflect [Yahoo! Finance]
Arcellx (NASDAQ:ACLX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings [Yahoo! Finance]
Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings